Skip to main content
SpringerLink
Log in

Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?

  • Editorial
  • Published:
Cancer Immunology Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cheever MA, Greenberg PD, Fefer A, Gillis S (1982) Augmentation of the anti-tumour therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified Interleukin-2. J Exp Med 155:968

    Article  PubMed  CAS  Google Scholar 

  2. Csako G, Binder RA, Kales AN, Neefe JR (1980) Cloning of human lymphocytes reactive with autologous leukemia cells. Cancer Res 40:3218

    PubMed  CAS  Google Scholar 

  3. Dennert G, Yogeeswaran G, Yamagata S (1981) Cloned cell lines with natural killer activity. J Exp Med 153:545

    Article  PubMed  CAS  Google Scholar 

  4. DeVries JE, Spits H (1984) Cloned human cytotoxic T lymphcyte (CTL) lines reactive with autologous melanoma cells. J Immunol 132:510

    CAS  Google Scholar 

  5. Fossati G, Balsari A, Taramelli D, Sensi ML, Pellegris G, Nava M, Parmiani G (1982) Lysis of autologous human melanoma cells by in vitro allosensitised peripheral blood lymphocytes. Cancer Immunol Immunother 14:99

    Article  PubMed  CAS  Google Scholar 

  6. Grimm EA, Mazumder A, Zhang Z, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumour cells by Interleukin-2-activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823

    Article  PubMed  CAS  Google Scholar 

  7. Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA (1983) Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes and natural killer cells. J Exp Med 157:884

    Article  PubMed  CAS  Google Scholar 

  8. Hercend T, Meuer S, Reinherz EL, Schlossman SF, Ritz J (1982) Generation of a cloned NK cell line derived from the “null cell” fraction of human peripheral blood. J Immunol 129:1299

    PubMed  CAS  Google Scholar 

  9. Hersey P, Bindon C, Edwards A, Murray E, Phillips G, McCarthy WH (1981) Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with Interleukin-2. Int J Cancer 28:695

    Article  PubMed  CAS  Google Scholar 

  10. Kimber I, Moore M (1983) Naturally cytotoxic tonsillar lymphocytes: a manifestation of heterogeneity among human NK cells. Scand J Immunol 17:29

    Article  PubMed  CAS  Google Scholar 

  11. Mazumder A, Rosenberg SA (1984) Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by Interleukin-2. J Exp Med 159:495

    Article  PubMed  CAS  Google Scholar 

  12. Mazumder A, Grimm EA, Zhang HZ, Rosenberg SA (1982) Lysis of fresh human solid tumours by autologous lymphocytes activated in vitro with lectins. Cancer Res 41:913

    Google Scholar 

  13. Mazumder A, Grimm EA, Rosenberg SA (1983) Lysis of fresh human solid tumour cells by autologous lymphocytes activated in vitro by allosensitisation. Cancer Immunol Immunother 15:1

    Article  PubMed  CAS  Google Scholar 

  14. Moore M, Taylor GM, White WJ (1982) Susceptibility of human leukaemias to cell-mediated cytotoxicity by interferon-treated allogeneic lymphocytes. Cancer Immunol Immunother 13:56

    Article  PubMed  CAS  Google Scholar 

  15. Mukherji B, MacAlister TJ (1983) Clonal analysis of cytotoxic T cell response against human melanoma. J Exp Med 158:240

    Article  PubMed  CAS  Google Scholar 

  16. Ortaldo JR, Timonen TT, Vose BM, Alvarez JA (1982) Human natural killer cells as well as T cells maintained in continuous cultures with IL-2. In: Fefer A, Goldstein A (eds) The potential role of T cells in cancer therapy. Raven Press, New York, p 191

    Google Scholar 

  17. Pawelec GP, Hadam MR, Schneider M, Wernet P (1982) Clonally restricted natural killer-like cytotoxicity displayed by cloned human T cell lines. J Immunol 129:2271

    PubMed  CAS  Google Scholar 

  18. Serrate SA, Vose BM, Timonen T, Ortaldo JR, Herberman RB (1982) Association of human natural killer cell activity against human primary tumours with large granular lymphocytes. In: Herberman RB (ed) NL cells and other natural effector cells. Academic Press, New York, p 1055

    Chapter  Google Scholar 

  19. Strausser JL, Mazumder A, Grimm EA, Lotze MT, Rosenberg SA (1981) Lysis of human solid tumours by autologous cells sensitised in vitro to alloantigens. J Immunol 127:266

    PubMed  CAS  Google Scholar 

  20. Vanky F, Klein E (1982) Specificity of auto-tumour cytotoxicity exerted by fresh, activated and propagated human T lymphocytes. Int J Cancer 29:547

    Article  PubMed  CAS  Google Scholar 

  21. Vanky F, Argov S, Einhorn S, Klein E (1980) The role of alloantigens in natural killing. Allogeneic but not autologous tumour biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphocytes. J Exp Med 151:1151

    Article  PubMed  CAS  Google Scholar 

  22. Vanky F, Gorsky T, Gorsky Y, Masucci M-G, Klein E (1982) Lysis of tumour biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor. J Exp Med 155:83

    Article  PubMed  CAS  Google Scholar 

  23. Vose BM (1982) Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site. Int J Cancer 30:135

    Article  PubMed  CAS  Google Scholar 

  24. Vose BM, Bonnard GD (1982) Limiting dilution analysis of the precursor cells capable of specific cytotoxic or proliferative responses to human tumour cells and their expansion with lectin-free interleukin-2. In: Serrou B et al. (eds) Current concepts in human immunology. Elsevier Biomedical Press, Amsterdam, p 385

    Google Scholar 

  25. Vose BM, Bonnard GD (1983) Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin-2. J Immunol 130:687

    PubMed  CAS  Google Scholar 

  26. Vose BM, Moore M (1980) Natural cytotoxicity in humans: susceptibility of freshly isolated tumour cells to lysis. JNCI 65:257

    PubMed  CAS  Google Scholar 

  27. Vose BM, Moore M (1981) Cultured human T-cell lines kill autologous solid tumours. Immunol Lett 3:237

    Article  PubMed  CAS  Google Scholar 

  28. Vose BM, White W (1983) Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Cancer Immunol Immunother 15:227

    Article  PubMed  CAS  Google Scholar 

  29. Vose BM, Riccardi C, Marchmont RJ, Bonnard GD (1982) Clonal analysis of human natural killer cells. In: Herberman RB (ed) NK cells and other natural effector cells. Academic Press, New York, p 879

    Chapter  Google Scholar 

  30. Zagury D, Morgan D, Lenoir G, Fouchard M, Feldman M (1983) Human normal CTL clones: Generation and properties. Int J Cancer 31:427

    Article  PubMed  CAS  Google Scholar 

  31. Zarling JM, Raich PC, McKeough M, Bach FH (1976) Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature 262:691

    Article  PubMed  CAS  Google Scholar 

  32. Zarling JM, Kay NE, Grant B, Yasukawa M, Bach FH (1983) Human antilymphoma responses generated in vitro and in vivo following sensitisation with allogeneic leukocytes. Cancer Immunol Immunother 15:237

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ICI Pharmaceuticals Division, Mereside, Alderley Park, SK10 4TG, Macclesfield, Cheshire, England

    B. M. Vose

Authors
  1. B. M. Vose
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vose, B.M. Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?. Cancer Immunol Immunother 17, 73–75 (1984). https://doi.org/10.1007/BF00200039

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00200039

Search

Navigation